Cover of: Serological tumour markers | J. E. Roulston Read Online
Share

Serological tumour markers an introduction by J. E. Roulston

  • 329 Want to read
  • ·
  • 89 Currently reading

Published by Churchill Livingstone in Edinburgh, New York .
Written in English

Subjects:

  • Tumor markers -- Diagnostic use.,
  • Neoplasms -- diagnosis.,
  • Tumor Markers, Biological -- diagnostic use.

Book details:

Edition Notes

Includes bibliographical references and index.

StatementJ.E. Roulston, R.C.F. Leonard ; foreword by K.D. Bagshawe.
ContributionsLeonard, R. C. F.
Classifications
LC ClassificationsRC270.3.T84 R68 1993
The Physical Object
Paginationxiii, 175 p. :
Number of Pages175
ID Numbers
Open LibraryOL1742362M
ISBN 100443045119
LC Control Number92049368

Download Serological tumour markers

PDF EPUB FB2 MOBI RTF

The purpose of this book-the fourth volume of a series on Can­ cer Markers-is intended to provide an updated "status report" on today's use of cancer markers in the diagnosis and monitoring of can­ cer, with an emphasis on cancer markers detected in the serum. It has been 7 years since  › Medicine › Pathology. SEROLOGICAL CANCER The declared purpose of this book, the fourth volume of a series on Cancer Markers, is â to provide an updated status report on todayâ s use of cancer markers in the diagnosis and monitoring of cancer, with an emphasis on cancer markers detected in the serumâ. The previous volumes were published in , and ; the intervals are increasing, suggesting perhaps Download PDF: Sorry, we are unable to provide the full text but you may find it at the following location(s): (external link) ISBN: OCLC Number: Description: xv, pages: illustrations ; 24 cm. Contents: Cancer markers of the s: an introduction / Stewart Sell --Clinical cancer markers: diagnosis, prognosis, and monitoring / Manfred L. Lüthgens and Peter Oehr --Alpha-fetoprotein in the s / Kazuhisa Taketa --Carcinoembryonic antigen / Hanna M. Sikorska, Abraham Fuks, and

Serological tumour markers: an introduction J.E. Roulston, R.C.F. Leonard ; foreword by K.D. Bagshawe Churchill Livingstone, Other glycoprotein markers, such as CA and CA, have shown some value, particularly in combination with CEA, in detecting and monitoring advanced GI cancers. The list of newer, potential markers is large and likely to expand at an increasing rate, especially in consequence of large-scale “omic” ://    tumour markers in clinical practice concepts and applications Posted By Richard ScarryLtd TEXT ID eaa2 Online PDF Ebook Epub Library medicine practice guidelines lpmg for the use of tumor markers in testicular prostate colorectal breast and ovarian cancers these guidelines are intended to encourage more ap propriate use of tumor marker   SEROLOGICAL MARKERS Serology is the science that deals with the characterization of serum, the noncellular component of blood. Serum contains many valuable proteins, nucleotides, and other chemicals that aid the physiological functions of the body. Between and , numerous scientific studies were performed to study the production of serum and its use in monitoring and /serological-markers.

An investigation of serological tumour markers in epithelial ovarian cancer Author: Fisken, Jane CA was elevated in a greater proportion of patients with all FIGO stages and histological tumour types than all other markers. Whilst serum p was elevated in very few patients, there were insufficient data (the major restriction being cost ?uin= The Science of Cancer – a closer look at the cell, genetics, the immune system, tumour markers and monoclonal antibodies. Research and Treatment – exploring translational oncology, applying research methodology to cancer research and research ethics relating to ://    tumour markers in clinical practice concepts and applications Posted By Danielle SteelPublic Library TEXT ID eaa2 Online PDF Ebook Epub Library Tumor Markers In Clinical Practice A Review Focusing On   markers. Similar findings were reported by Mani R et al. The levels of these tumor markers dropped significantly following appropriate treatment. Combination of CEA, AFP and ß-HCG in malignant ovarian may give more effective result than using a single biomarker. TUMOR MARKERS IN DIAGNOSIS OF OVARIAN MALIGNANCY Professional Med J ;21(4